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Caper (Capparis ovata Desf. and Capparis spinosa L.) is naturally widespread in Turkey. Traditionally, 
buds, fruits, seeds and roots of this plant are used as tonic, diuretic, anti-rheumatic, expectorant, 
antidiabetic, and antifungal. The aim of this study is to evaluate potential hypoglycemic effect of C. 
ovata var. palaestina extracts in alloxan-induced diabetic mice. For this purpose; diabetic mice were 
administered with 100, 300, 500 mg/kg (i.p.) doses of methanol extract of bud and fruit. Blood glucose 
levels were screened 60, 120, 240 and 360 min. after treatment. Furthermore, high resolution mass 
spectrometry (HRMS) analysis, ABTS and DPPH free radical scavenging activity test, and phenolic and 
flavonoid compounds analysis of extracts were carried out. The data obtained from in vivo study revealed 
that fruit-methanol 500 mg/kg (FM3), bud-methanol 300 mg/kg (BM2), bud-methanol 500 mg/kg (BM3) 
extracts showed significant hypoglycemic activity. All extracts indicated significant antioxidant activity, 
however bud-methanol (BM) extract demonstrated the most potent antioxidant activity. Moreover high 
levels of phenolic substances and flavonoids were involved in all extracts, but the highest levels were found 
in FM extract. HRMS study showed that rutin, quercetin 3-O-glucoside (isoquercitrin) and stachydrine 
substances had seen in BM extract. The results of this study showed that the C. ovata var. palaestina 
extracts which, indicate hypoglycemic, antioxidant activities, might provide additional support in diabetes.
Keywords: C. ovata var. palaestina/extract. C. ovata var. palaestina/hypoglycemic effect/antioxidant 
effects. Diabetes mellitus. Mice.
INTRODUCTION
Diabetes mellitus (DM) is a group of metabolic 
diseases which characterized by high blood glucose 
(hyperglycemia) resulting from either defects in insulin 
secretion, or insufficient insulin action, or both. The 
chronic hyperglycemia can induce failure or dysfunction 
of diffirent organs, especially the eyes, kidneys, nerves, 
heart, and blood vessels (ADA, 2010). According to the 
World Health Organization (WHO) report, prevalence of 
DM is globally about 171 million and predicted to reach 
366 million by the end of 2030 (Manaer et al., 2015). DM 
is exactly recognized as a global public health problem, 
considered the most challenging metabolic endemic of the 
21st century (Okur et al., 2017).
Type 1 diabetes is a chronic illness characterized by 
insulin deficiency. Therefore different types of insulin such 
as fast acting insulins involving lispro, aspart, glulisine, 
and long acting insulins possessing detemir, glargine, 
degludec and finally the intermediate acting insulins 
are used for treatment of type 1 diabetes. Metformin 
is the main drug for the treatment of type 2 diabetes. 
Depending on the HbA1c values, different types of 
drugs such as dipeptidyl peptidase-4 (DPP-4) inhibitors, 
thiazolidinediones, sulfonylureas, sodium glucose co-
transporter (SGLT2) inhibitors, glucagon like peptide-1 
(GLP-1) receptor agonists and insulin might be added at 
different levels to dual or triple therapy of treatment of 
type 2 diabetes (ADA, 2017).
Despite the currently available conventional drugs 
the treatment of diabetes has been a difficult task. This is 
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due to the unwanted side effects associated with the use 
of the conventional drugs, which include hypoglycemia, 
weight gain, hypersensitivity, gastrointestinal discomfort, 
nausea, liver and heart failure, and diarrhea (Mohammed 
et al., 2016). Apart from conventional antidiabetic therapy, 
several studies have shown that diet, use of medicinal 
plants, complementary and alternative medicine therapies 
have beneficial effects and improve glucose homeostasis 
in diabetic patients (Fallah Huseini et al., 2013). It is a 
necessity to research for effective, economic, accessible, 
and safe drug candidates for treatment of DM. Thus 
researching the effectiveness of plants could be a good 
option (Sheikh et al., 2016).
Capparis species (Capparaceae), also known as 
Caper is represented by about 250 species as well as 
has wide natural distribution in many different regions 
worldwide. Caper has been used traditionally for several 
therapeutic effects since ancient times such as diuretic, 
laxative, analgesic (Arslan, Bektas, 2010; Tlili et al., 
2011). In addition, antidiabetic activities of several 
species such as C. decidua (Yadav et al., 1997), C. spinosa 
(Kazemian et al., 2015), and C. moonii (Kanaujia et al., 
2010) have been shown. The biological activities that 
Caper species have shown are due to their bioactive 
contents such as glucosinolates, alkaloids, flavonoids and 
phenolic acids (Arslan, Bektas, Ozturk, 2010; Gull et al., 
2015). In Turkey, two species (C. spinosa and C. ovata) 
of Capparis L. are grown and each species is represented 
by three varieties. These varieties are: C. spinosa L. var. 
spinosa L., C. spinosa L. var. inermis Turra., C. spinosa 
L. var. aegyptia (Lam) Boiss, and; C. ovata Desf. var. 
palaestina Zoh., C. ovata Desf. var. herbacea (Wild) 
Zoh., and C. ovata Desf. var. canescens (Coss.) Heywood 
(Özbek, Kara, 2013) .
The aim of the present study is to evaluate 
hypoglycemic and antioxidant activities of Capparis 
ovata Desf. var. palaestina Zoh., which has not reported 
its biological effects on diabetes before. Along with in vivo 
hypoglycemic activity test of C. ovata var. palaestina 
methanol extracts, DPPH and ABTS•+ free radical 
scavenging activity studies were examined. Therewithal, 
in order to determine phytochemical constituents, phenolic 
and flavonoid substances were investigated and also 
extracts were quantitatively analyzed by using HRMS. 
MATERIAL AND METHODS
Plant material 
In the present study, buds and fruits of C. ovata 
var. palaestina (Capparidaceae), collected from Batman, 
Turkey. Voucher samples were deposited in Herbarium 
of Ankara University Faculty of Pharmacy (No: *AEF 
26797, *AEF 26798). *(AEF:Ankara Üniversitesi Eczacılık 
Fakültesi Herbaryumu)
Laboratory animals 
BALB-c mice (25-28 g) were procured from İstanbul 
Medipol University, MEDITAM, İstanbul, Turkey. The 
mice were hosted in regular cages with food and water 
ad libitum, at room temperature (20±2 °C) with artificial 
light from 7.00 am to 7.00 pm. Prior to perform in vivo 
experiments, ethical clearance approval was obtained from 
the Institutional Animals Ethical Committee (Approval 
No.–38828770-604.01.01-E.5775). All procedures 
involving animals were conducted in accordance with the 
National Institutes of Health (NIH) Guide for the Care and 
Use of Laboratory Animals (NIH publication no. 85-23, 
revised in 1985).
Preparation of Capparis ovata var. palaestina 
extracts
Buds and fruits of C. ovata var. palaestina were 
air-dried, then powdered. For methanolic extracts, each 
samples were extracted with methanol for 24 h. After 
filtered, the extracts were concentrated in vacuo at 40 °C. 
The dry residue was stored at 4 °C. The extract yields of 
fruits were calculated as 10.21% (w/w) while as the extract 
yields of buds were calculated as 12.26% (w/w).
Induction of diabetes and experimental design
Mice  were  f a s t ed  fo r  18  hou r s  and  t hen 
diabetes was induced by intraperitoneal (i.p.) alloxan 
(150 mg/kg) injection to mice. This treatment was 
repeated 3 times with 48 hours intermission between per 
injections to induce diabetes in mice. 7 days after the final 
alloxan injection, mice with fasting blood glucose above 
200 mg/mL were found to be sufficient for experimental 
diabetes and included in the study (Öntürk, Özbek, 2009).
Animal grouping, dose determination and extract 
administration
Animals were fasted eighteen hours before the 
experiments, but were allowed to water consumption. 
Mice were indiscriminately divided into fifteen groups 
each involving five animals: Group 1, diabetic mice 
received bud-methanol extract (100 mg/kg, i.p.)-(BM1); 
Group 2, diabetic mice received bud-methanol extract 
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(300 mg/kg, i.p.)-(BM2); Group 3, diabetic mice received 
bud-methanol extract (500 mg/kg, i.p.)-(BM3); Group 4, 
diabetic mice received fruit-methanol extract (100 mg/kg, 
i.p.)-(FM1); Group 5, diabetic mice received fruit-
methanol extract (300 mg/kg, i.p.)-(FM2); Group 6, 
diabetic mice received fruit-methanol extract (500 mg/kg, 
i.p.)-(FM3); Group 7, diabetic mice received glibenclamide 
(control - 3 mg/kg, i.p.)-(GC); Group 8, diabetic mice 
received normal saline (control - 0,1 mL 0.9% NaCl, i.p.)-
(DC); Group 9, normoglycemic mice received normal saline 
(control - 0,1 mL 0.9% NaCl, i.p.)-(NC). Blood samples 
were taken from the tail vein of mice at 0 min (before 
treatment) and 60, 120, 240 and 360 min after treatment. 
Blood glucose level was monitored by applying glucose 
oxidase peroxidase method (Abbott, United Kingdom).
In vitro antioxidant activity
DPPH• Free radical scavenging activity
The (2,2-diphenyl-1-picrylhydrazyl) DPPH free 
radical scavenging activity of extracts were detected by 
their capacity of bleaching the stable radical DPPH (Blois, 
1958). The reaction solution consisted of a mixture of 
100 M DPPH in methanol with different concentrations 
of the extract. After 0.5 h at room temperature, absorbance 
was measured at 517 nm, and the free radical scavenging 
activity was detected as the percentage of the radical 
reduction. Each test was repeated three times. IC50 
values were detected from a calibration graph for each 
prepared extracts. As reference compound, butylated 
hydroxytoluene (BHT) was used. 
Percentage of inhibition = [(Optical densitycontrol –  
Optical densitytest sapmLe) / Optical densitycontrol)] x 100
ABTS•+ Free radical scavenging activity
Antioxidant activity of the extracts was determined 
by [2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)] 
ABTS radical cation decolorization test (Re et al., 1999). 
The ABTS radical cation was produced by mixing ABTS 
stock solution (7 mM in water) with 2.45 mM potassium 
persulfate. Subsequently, this mixed solution was kept for 
12-16 h. at room temperature in a dark room before usage. 
The ABTS solution was diluted with ethanol to regulate an 
absorbance value of 0.70±0.02 at 734 nm. The sample was 
diluted 100-fold with the ABTS solution to a total volume 
of 1 mL. The absorbance of the solution was detected 
spectrophotometrically at 734 nm 6 min after preparation 
and the percentage of inhibition was calculated. Each test 
was performed at least in triplicates. Controls without 
ABTS were used to allow for any absorbance of the extracts 
themselves and 990 µL of ethanol was added to these 
control samples instead. Because of self-degradation of the 
radical, ABTS stock solutions were freshly prepared in every 
5 days. The test was primary performed on Trolox (used as 
standard) which is a water-soluble α-tocopherol analogue. 
The results were expressed as IC50.
Percentage of inhibition = [(Optical densitycontrol –  
Optical densitytest sapmLe) / Optical densitycontrol)] x 100
Analysis of phenolic and flavonoid compounds 
Determination of total phenolic contents of the 
extracts 
The amount of phenolic content in the extracts were 
measured according to Folin-Ciocalteu technique. 5 mL 
of each extract, 0.25 mL 10% Folin-Ciocalteau’s reagent 
(v/v) and 0.2 mL 7.5% Na2CO3 (w/v) were mixed. Then 
sample was incubated at 45 °C for 15 min. The absorbance 
of each sample was determined at 765 nm. The total 
phenolic content was measured from a calibration curve 
(R2 = 0.9811) and final values were expressed as mg gallic 
acid equal per 100 g extract. For all samples, each test was 
repeated thrice (Heydari, Saltan, Acikara, 2015).
Determination of total flavonoid contents of the 
extracts 
The amount of flavonoid content in the extracts 
were determined by the aluminium chloride colorimetric 
assay. In brief, 50 μL of extract was completed to 1 mL 
with methanol, then 4 mL of distilled water and 0.3 mL 
5% NaNO2 solution were added and mixed. Followed by 
5 min incubation, 0.3 mL 10% AlCl3 solution was added 
and the mixture was allowed to wait for 6 min. Then, 
2 mL 1 mol/L NaOH solution were added. Finally, the 
mixture was completed to 10 mL with double-distilled 
water and was allowed to wait for 15 min. The absorbance 
of each sample was determined at 510 nm. The total 
flavonoid content was measured from a calibration curve 
(R2 = 0.9978) and final values were expressed as mg 
quercetin equivalent per 100 g extract. For all sample, each 
test was repeated thrice (Chia-Chi Chang et al., 2002).
High-resolution mass spectrometry (HRMS)
HRMS analysis were performed on a hybrid IT-TOF 
mass spectrometer with ESI interface (both positive and 
negative mode) (Shimadzu, Kyoto, Japan). The positive 
ESI conditions were as follows: high voltage probe, 
-3.5 kV (for negative ESI, it was 3.5 kV); nebulizing gas 
flow, 1.5 L/min; CDL temperature, 200 °C; heat block 
temperature, 200 °C; drying gas pressure, 200 KPa. 
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CID parameters were settled 50% for CID energy, 50% 
for collision gas parameter and Argon gas was used for 
CID. Detector voltage of TOF was 1.6 kV. A solution 
of trifluoroacetic acid (TFA) and sodium hydrate was 
consumed as the standard sample for postrun calibration. 
LC part was consisted of two LC-20AD dual pump, 
DGU-20A3R degasser unit, CTO-10ASvp column oven, 
SIL-20AC autosampler and SPD-M20A PDA detector. In 
the analysis, inertsil ODS-3 (150 mm x 1.5 mm, 5 um), 
were used as stationary phase and the mix of Water/
Acetonitrile (0.1 % Formic acid) was used gradually 
as mobile phase. Data were processed by using LCMS 
solution software (v. 3.80). In high resolution mass 
spectrometer analysis, extracts were dissolved in methanol 
and injected to system as 1 µL injection volume.
Statistical analysis
In vivo test results are presented as mean ± standard 
error of the mean (SEM). Statistical analysis of in vivo test 
results was performed using one-way ANOVA followed by 
Dunnett’s post-tests using the Graphpad ver. 5 software. 
Antioxidant test results are presented as mean ± standard 
deviation (SD). Statistical analysis of antioxidant test 
results was completed using one-way ANOVA with the 
SPSS 23.0 software. A difference in the mean values of 
P<0.05 was considered to be statistically significant.
RESULTS AND DISCUSSION
It has been stated that different Capparis species such 
as, C. aphylla (Dangi, Mishra, 2010), C. mooni (Kanaujia 
et al., 2010), C. zeylanica (Deepa, Jasmine, Agastian, 
2013), C. decidua (Yadav, Sarkar, Bhatnagar, 1997) and 
C. spinosa (Mishra et al., 2012) indicate effectiveness on 
diabetes. Along with this, the hypoglycemic effects of C. 
ovata varieties has not been researched before. According 
to previous studies which were performed with C. ovata 
varieties; It was administered at a dose range of 100-2000 
mg/kg and no toxic effect was observed in mice. However, 
it has been indicated that methanol extracts of fruit and 
bud (100, 200, 300 mg/kg-i.p.) have antithrombotic and 
anti-inflammatory effects and methanol extract of fruit (50, 
100, 200 mg/kg-i.p.) have antinociceptive effect (Arslan, 
Bektas, Ozturk, 2010; Bektas et al., 2012).
Acute effects of C. ovata var. palaestina extracts 
on blood glucose levels in diabetic mice 
Alloxan destroy pancreatic β-cells to induce 
hyperglycemia. Its notified that range of 140-180 mg/kg 
dose range of alloxan may be efficient for this purpose 
in mice (Eddouks, Lemhadri, Michel, 2005), besides 
this 150 mg/kg alloxan might cause adequate and non-
excessive diabetes (Öntürk, Özbek, 2009). Therefore the 
dose of alloxan was selected 150 mg/kg (i.p.).
Fasting blood glucose (FBG) levels after single 
i.p. application of methanol extracts of C. ovata var. 
palaestina’s buds and fruits are shown in Table I. 
Accordingly, depending on the mean results of FBG in 
diabetic mice at 0, 60, 120, 240 and 360 minutes; BM1, 
BM2, BM3, FM3, GC treatments showed continuous 
reduction of FBG with time when compared to initial 
time (0 min), whereas FM1, FM2 and DC treatments 
showed an increase of FBG at 60 min then showed 
continuous reduction. Additionally, normoglycemic 
control (NC) group mostly showed continuous reduction 
of FBG with time when compared to initial time (0 min). 
It was observed that fasting blood glucose levels were 
decreasing in a dose dependent manner with both fruit 
and bud extracts. Furthermore, the highest reduction rate 
in the extract treatments was seen in the BM3 group. 
Treatments that cause fasting blood glucose to decrease 
below 200 mg/dL in diabetic mice are GC (240-360 min) 
and BM3 (360 min) (Table I). 
Figure 1 depicted that the hypoglycemic effect of 
C. ovata var. palaestina’s fruit and bud methanol extracts 
on the fasting blood glucose in normal and diabetic mice. 
The administration of the glibenclamide (3 mg/kg, i.p)-
(GC) significantly decreased blood glucose at 60 min 
(**P<0.01), 120 min (**P<0.01), 240 min (***P<0.001) 
and 360 min (***P<0.001) when compared with diabetic 
control (DC) group in diabetic mice. The administration 
of the fruit extracts; FM3 (500 mg/kg) group at 360 min 
(*P<0.05) significantly decreased blood glucose when 
compared with DC group in diabetic mice. However 
no significant difference in blood glucose levels was 
observed with FM1 (100 mg/kg) and FM2 (300 mg/kg) 
groups. The administration of the bud extracts; BM1 
(100 mg/kg) and BM2 (300 mg/kg) groups did not show 
any significant change on blood glucose level. On the 
other hand, BM3 (500 mg/kg) at 240 min (*P<0.05), 
and 360 min (***P<0.001), significantly decreased blood 
glucose when compared with DC group in diabetic mice. 
The mechanism of potential hypoglycemic effect 
which is exhibited by C. ovata var. palaestina’s extracts, 
might be the result of potentiation of the insulin secration 
or effect. It is also thought one of the mechanisms of 
hypoglycemia induced by C. ovata var. palaestina 
extracts is an pancreatic mechanism (Almeida et al., 
2006). Moreover, several compounds such as saccharides, 
glycosides, alkaloids, terpenoids, volatile oils, fatty acids, 
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steroids, several minerals might effect glucose or insulin 
metabolism (Fallah Huseini et al., 2013). 
In vitro antioxidant activity
Diabetes is an oxidative stress based disorder which is 
caused by an imbalance between the cellular production of 
reactive oxygen species and the deactivating these products 
by natural antioxidant mechanisms of body (Gothai et 
al., 2016). Oxidative stress has a critical role in systemic 
inflammation, endothelial dysfunction, impaired secretion 
of pancreatic β-cells and impaired glucose utilization in 
peripheral tissues (Zatalia, Sanusi, 2013). Free radical 
formation in diabetes by non-enzymatic glycation of 
proteins, glucose oxidation and increased lipid peroxidation 
leads to damage of enzymes, cellular machinery and 
also increased insulin resistance due to oxidative stress 
(Ullah, Khan, Khan, 2016). Therefore, plants which have 
antioxidant activity, can enhance β-cell function and the 
insulin secretion from the islets of Langerhans (Jerine 
Peter, Sabina, 2016). Hereby, antioxidants might have an 
important role in the relieving of DM (Jayasri et al., 2008). 
Several studies have exhibited the antioxidant activity of C. 
ovata L. (Ünver et al., 2009), C. ovata Desf. var. canescens 
(El-Ghorab, Shibamoto, Özcan, 2007) and C. ovata subsp. 
ovata (Aichi-Yousfi et al., 2016). 
TABLE I - Acute effects of methanol extracts of C. ovata var. palaestina bud and fruit on fasting blood glucose levels (mg/dL) in 
diabetic mice. Values are presented as the mean±SEM
Group 0 min 60 min 120 min 240 min 360 min
BM1 333.4±56.196 321.2 ±71.810 287.8±75.303 270.2±73.393 244.8 ±75.813
BM2 338.2±34.420 337.4±25.295 294.4±36.215 271.8±41.693 215.8±64.366
BM3 325.2±35.012 313.8±37.747 309.2±40.940 226.6±44.536 147.4±32.873
FM1 311±27.969 340.6 ±29.696 325.2±16.035 304.4±20.934 234.6±40.708
FM2 372.8±15.951 374.2±18.529 373.4±20.903 299.6±27.312 258.4±38.347
FM3 378.4±36.104 360.4±32.103 336.6±39.618 280.2±34.245 225.4 ±38.405
GC 332.8±52.336 232.2±47.276 210.6±38.771 139.6±12.548 138.4±12.548
DC 402.8±48.89 454±57.31 443.2±66.58 410.2±66.34 390.4±69.5
NC 149.8±11.62 140.6±6.249 135.6±6.265 144.4±8.298 115.8 ±9.702
FIGURE 1 - The hypoglycemic effect of fruits-buds of C. ovata var. palaestina’s methanol extracts. Values are presented as the 
mean±SEM. DC: diabetic control, GC: glibenclamide-control, NC: normoglycemic-control, FM1: fruit methanol 100 mg/kg, FM2: 
fruit methanol 300 mg/kg, FM3: fruit methanol 500 mg/kg, BM1: bud methanol 100 mg/kg, BM2: bud methanol 300 mg/kg, BM3: 
bud methanol 500 mg/kg. *P<0.05, **P<0.01, ***P<0.001; significant difference from diabetic-control (DC) group.
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In general, it is an acceptable application to test 
antioxidant activities of samples with two different 
analyzing methods (El-Ghorab, Shibamoto, Özcan, 
2007). In our study, antioxidant activity of extracts were 
analyzed by DPPH and ABTS free radical scavenging 
activity test. DPPH and ABTS free radical scavenging 
test values of C. ovata var. palaestina extracts were 
presented in Table II. According to the DPPH test results, 
BM has shown the highest activity (0.096±0.007 mg/
mL), furthermore both extracts also had significant 
free radical scavenging activities as compared to 
butylated hydroxytoluene (BHT) (P<0.05). On the 
other hand, according to other (ABTS) test results, BM 
was characterized by the highest antioxidant activity 
(0.063±0.009 mg/mL) as well as both extracts have 
significant free radical scavenging activities as compared 
to Trolox (P<0.05). Both test (ABTS and DPPH) results 
were indicated the strong resemblance. BM have a higher 
free radical scavenging activities than FM. Antioxidant 
activity that depicted in the extracts, might contribute to 
in vivo antidiabetic effect.
Analysis of phenolic and flavonoid compounds
Plant originated antioxidants are grouped as 
vitamins, phenolic compounds and flavonoids (El-Ghorab, 
Shibamoto, Özcan, 2007). It is indicated that phenolic 
acids and flavonoids have effectiveness in treating diabetes 
and its complications due to potent antioxidant activity 
(Gu et al., 2015). Capparis species have rich alkaloids, 
lipids, polyphenols, flavonoids, and glucosinolates 
(Nazıroğlu et al., 2011)
In this study phenolic compounds in C. ovata 
var. palaestina extracts were measured by using Folin-
Ciocalteu reagent. Total phenolic compound of two extract 
of C. ovata var. palaestina were screened. The lowest 
total phenolic value was 603.25±4.24 mgGAE/100 g 
from bud extract and the highest total phenolic value was 
1017.42±44.18 mgGAE/100 g from fruit extract. Various 
factors such as; solvent, geographic origin, stresses of 
environment were linked to these content variations 
(Aichi-Yousfi et al., 2016).
Flavonoids are one of the most common group of 
plant phenolics are flavonoids which could be graded 
such as flavones, flavonols, flavanones, flavonols, 
anthocyanins and isoflavonoids. (Guimarães et al., 2013). 
It is recognized that flavonoids which display potent 
antioxidant activity, can prop the regeneration of β-cells. 
(Liu et al., 2016). Total flavonoid compound of two extract 
of C. ovata var. palaestina were screened. The lowest total 
flavonoid value was 1940±4.24 mgQE/100 g from bud 
extract and the highest was 2990±21.21 mgQE/100 g from 
fruit extract. Tlili et al. stated that antioxidant activities 
of C. spinosa are related to the high level of phenolic 
compounds (Tlili et al., 2011).
According to obtained results, it was seen that fruit 
extract contains 1.5 times more flavonoid and phenolic 
substance than bud extract. BM extract which was 
indicated in vivo hypoglycemic activity, had the lowest 
phenolic/flavonoid content and showed potent antioxidant 
effect. Although the FM extract had more phenolic and 
flavonoid substances, it exhibited lower antioxidant 
activity and weaker hypoglycemic activity. 
High-resolution mass spectrometry (HRMS)
Results both positive and negative mode were 
evaluated by literature knowledge and database on 
drugbank.ca. The identification of the compounds was 
carried out mainly by applying the mass fragmentation 
rules. A total of 3 components were detected in the BM 
extract using IT-TOF. Quercetin 3-O-glucoside, Rutin and 
Stachydrine were determined from the spectrum (Table 
III). The identities of 3 components were unambiguously 
determined by comparing their retention times and mass 
spectra with those of the pure compounds. 
Rutin is a phenolic compound which has antioxidant, 
antidiabetic and anti-inflammatory activities. Rutin which 
has several effect on diabetes (Niture, Ansari, Naik, 2014), 
was investigated in C. ovata var. palaestina extracts by 
TABLE II - Antioxidant activity results of C. ovata var. palaestina extracts
Extract DPPH-IC50 (mg/mL) ABTS-IC50 (mg/mL)
Fruit-Methanol (FM) 0.343* ±0.033 0.106* ±0.001
Bud-Methanol (BM) 0.096* ±0.007 0.063* ±0.009
Reference  DPPH-IC50 (mg/mL) ABTS-IC50 (mg/mL)
Butylated hydroxytoluene (BHT) 0.018* ±0.001  -
Trolox -  0.015* ±0.001
(*) Statistically significant as compared to control, P<0.05 (one-way ANOVA)
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HRMS method to determine possible hypoglycemic 
mechanism. It is previously reported that rutin was found 
in different parts of C. moonii and C. spinosa (Gull et al., 
2015).
Isoquercitrin exhibits a broad range of positive 
biological effects both in vitro and in vivo, especially 
chemoprotective activities against oxidative stress, 
cancer, cardiovascular disorders, diabetes and allergic 
reactions. Panda et al. were evaluated the potential 
antidiabetic activity of isoquercitrin in rats. Isoquercitrin 
(15 mg/kg/day, p.o. for 10 days) inhibited aloxan-induced 
hyperglycemia, hepatic and renal lipid peroxidation and 
the activity of hepatic glucose-6-phosphatase, while the 
activities of catalase and superoxide dismutase, and the 
content of glutathione were increased (Panda, Kar, 2007). 
In another study, isoquercitrin (single dose 100 mg/kg, 
p.o.) also delayed the glycemic peak by 30 min in 
oral glucose tolerance tests and thus exhibited a time-
dependent anti-hyperglycemic activity (Paulo et al., 2008). 
Stachydrine, as all betaines, is a quaternary 
ammonium compound. Betaines are ubiquitous in the 
vegetal world and tend to accumulate in the cytoplasm 
and intercellular fluids where they play an important 
role in protecting proteins, nucleic acids, and cell 
membranes against abiotic stress (Kavi Kishor et al., 2005; 
Street, Bolen, Rose, 2006). In a study, a high-glucose 
(30 mM) cell culture model was used to simulate clinical 
hyperglycemia for the in vitro evaluation of the effect of 
stachydrine on high-glucose induced cytotoxicity. Servillo 
et al. clearly established that stachydrine, an abundant 
component of citrus juices, is able to prevent the high-
glucose cytotoxicity in endothelial cell by acting on the 
senescence and SIRT1 pathways (Servillo et al., 2013).
CONCLUSION
In conclusion, the present study can be considered as 
the first report focusing on hypoglycemic and antioxidant 
activity of C. ovata var. palaestina methanol extracts. The 
data obtained from in vivo study revealed that FM3, BM2, 
BM3 extracts showed significant acute hypoglycemic 
activity. All extracts indicated significant antioxidant 
activity, moreover BM extract demonstrated the most 
potent antioxidant activity. Furthermore, all extracts were 
involving high levels of phenolic substances and flavonoids, 
besides the highest levels were found in FM extracts. In the 
HRMS study, rutin, isoquercitrin and stachydrine substance 
was found in BM extract. The results of our study suggest 
that C. ovata var. palaestina is a valuable canditate for 
further research as alternative therapy for the management 
of DM and other associated complications. 
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